YangXue QingNao Wan and Silibinin Capsules, the Two Chinese Medicines, Attenuate Cognitive Impairment in Aged LDLR (+/-) Golden Syrian Hamsters Involving Protection of Blood Brain Barrier

The purpose of the study was to explore the effect and the underlying mechanism of YangXue QingNao Wan (YXQNW) and Silibinin Capsules (SC), the two Chinese medicines, on cognitive impairment in older people with familial hyperlipidaemia. Fourteen month-old female LDLR (+/-) golden Syrian hamsters we...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, You-Yu, Huang, Ping, Li, Quan, Liu, Yu-Ying, Liu, George, Wang, Yu-Hui, Yi, Ming, Yan, Li, Wei, Xiao-Hong, Yang, Lei, Hu, Bai-He, Zhao, Xin-Rong, Chang, Xin, Sun, Kai, Pan, Chun-Shui, Cui, Yuan-Chen, Chen, Qing-Fang, Wang, Chuan-She, Fan, Jing-Yu, Ma, Zhi-Zhong, Han, Jing-Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Physiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992341/
https://www.ncbi.nlm.nih.gov/pubmed/29910744
http://dx.doi.org/10.3389/fphys.2018.00658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992341/
https://www.ncbi.nlm.nih.gov/pubmed/29910744
http://dx.doi.org/10.3389/fphys.2018.00658

Ejemplares similares